118 related articles for article (PubMed ID: 7577592)
1. Treatment of severe localized scleroderma by plasmapheresis--report of three cases.
Wach F; Ullrich H; Schmitz G; Landthaler M; Hein R
Br J Dermatol; 1995 Oct; 133(4):605-9. PubMed ID: 7577592
[TBL] [Abstract][Full Text] [Related]
2. Reactivity to anti-RNA polymerase III antibody and nailfold capillary changes in patient with generalized morphea combined with multiple autoimmune disorders.
Miyagawa F; Asada H
Eur J Dermatol; 2018 Feb; 28(1):112-113. PubMed ID: 29171400
[No Abstract] [Full Text] [Related]
3. Antinuclear antibodies in children with localized scleroderma.
Rosenberg AM; Uziel Y; Krafchik BR; Hauta SA; Prokopchuk PA; Silverman ED; Laxer RM
J Rheumatol; 1995 Dec; 22(12):2337-43. PubMed ID: 8835572
[TBL] [Abstract][Full Text] [Related]
4. Childhood multiple sclerosis treated with plasmapheresis.
Takahashi I; Sawaishi Y; Takeda O; Enoki M; Takada G
Pediatr Neurol; 1997 Jul; 17(1):83-7. PubMed ID: 9308985
[TBL] [Abstract][Full Text] [Related]
5. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
[TBL] [Abstract][Full Text] [Related]
6. Antihistone antibodies in patients with localized scleroderma.
Sato S; Ihn H; Soma Y; Igarashi A; Tamaki T; Kikuchi K; Ishibashi Y; Takehara K
Arthritis Rheum; 1993 Aug; 36(8):1137-41. PubMed ID: 8343189
[TBL] [Abstract][Full Text] [Related]
7. A case of nodular scleroderma.
Melani L; Caproni M; Cardinali C; Antiga E; Bernacchi E; Schincaglia E; Fabbri P
J Dermatol; 2005 Dec; 32(12):1028-31. PubMed ID: 16471471
[TBL] [Abstract][Full Text] [Related]
8. [Plasmapheresis in systemic sclerosis and polymyositis/dermatomyositis].
Matsuda M
Nihon Rinsho; 2004 May; 62 Suppl 5():568-71. PubMed ID: 15197986
[No Abstract] [Full Text] [Related]
9. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S
Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
[TBL] [Abstract][Full Text] [Related]
10. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases.
Prinz JC; Kutasi Z; Weisenseel P; Pótó L; Battyáni Z; Ruzicka T
J Am Acad Dermatol; 2009 Feb; 60(2):248-55. PubMed ID: 19022534
[TBL] [Abstract][Full Text] [Related]
11. [Extracorporeal photopheresis--treatment option in scleromyxedema?].
Durani BK; Bock M; Näher H
Hautarzt; 2001 Oct; 52(10 Pt 2):938-41. PubMed ID: 11715388
[TBL] [Abstract][Full Text] [Related]
12. Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.
Mimra Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
Int J Dermatol; 2005 Oct; 44(10):817-20. PubMed ID: 16207181
[TBL] [Abstract][Full Text] [Related]
13. [Clinical characteristics of patients with juvenile localized scleroderma].
Sun QN; Du W; Hu B; Liu P; Yuan X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Feb; 31(1):48-50. PubMed ID: 19317059
[TBL] [Abstract][Full Text] [Related]
14. Case of localized scleroderma associated with osteomyelitis.
Muroi E; Ogawa F; Yamaoka T; Sueyoshi F; Sato S
J Dermatol; 2010 Jan; 37(1):81-4. PubMed ID: 20175843
[TBL] [Abstract][Full Text] [Related]
15. Anti-U3 snRNP antibodies in localised scleroderma.
Yimane K; Ihn H; Kubo M; Asano Y; Yazawa N; Tamaki K
Ann Rheum Dis; 2001 Dec; 60(12):1157-8. PubMed ID: 11760725
[No Abstract] [Full Text] [Related]
16. Case of localized scleroderma successfully treated with bath psoralen and ultraviolet A therapy.
Uchiyama M; Okubo Y; Kawashima H; Yamamoto K; Mitsuhashi Y; Tsuboi R
J Dermatol; 2010 Jan; 37(1):75-80. PubMed ID: 20175842
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against antigens related to scleroderma in a cohort of patients with morphea.
Arisi M; Cavazzana I; Cerutti ME; Ferrari F; Carabellese N; Rossi MT; Tincani A; Calzavara-Pinton P; Franceschini F
G Ital Dermatol Venereol; 2018 Aug; 153(4):451-458. PubMed ID: 27706114
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to Th/To ribonucleoprotein in patients with localized scleroderma.
Yamane K; Ihn H; Kubo M; Kuwana M; Asano Y; Yazawa N; Tamaki K
Rheumatology (Oxford); 2001 Jun; 40(6):683-6. PubMed ID: 11426027
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to HMG-17 nucleosomal protein in patients with scleroderma.
Vlachoyiannopoulos PG; Boumba VA; Tzioufas AG; Seferiadis C; Tsolas O; Moutsopoulos HM
J Autoimmun; 1994 Apr; 7(2):193-201. PubMed ID: 8037838
[TBL] [Abstract][Full Text] [Related]
20. Plasmapheresis and immunosuppressive drug therapy in scleroderma.
Dau PC; Kahaleh MB; Sagebiel RW
Arthritis Rheum; 1981 Sep; 24(9):1128-36. PubMed ID: 6975636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
